Roche to unveil lung, breast cancer data at ESMO 2026

The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020.

The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. (REUTERS/Arnd Wiegmann)


1 photo
Save Story

Estimated read time: Less than a minute

BERLIN, Oct 19 — Roche ​said on Monday it will present ‌new late-stage trial results ⁠at ​the ESMO ⁠2026 cancer ‌meeting in ‌Madrid, including data ⁠showing ⁠its lung cancer drug divarasib worked better than current KRAS G12C treatments.

The ‌company ​will also show data that its breast cancer pill giredestrant improved outcomes without hurting patients' ​quality ‌of life, ‌and ⁠that its experimental drug Tam-Peli showed strong results ‌in several hard-to-treat ​tumours.

(Reporting ‌by Kirsti ⁠Knolle; ​Editing by Tom ​Hogue)

Photos

Most recent Lifestyle stories

Related topics

STAY IN THE KNOW

Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Notice.
Newsletter Signup

KSL Weather Forecast

KSL Weather Forecast
Play button